Sodium Phosphates
NDC 63323-886, sodium phosphate, monobasic, monohydrate and sodium phosphate, dibasic, anhydrous, injection, solution, from Fresenius Kabi USA, LLC.
- Product NDC
- 63323-886
- Status
- Listed
- Labeler
- Fresenius Kabi USA, LLC
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA209997
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/63323-886 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE276 mg/mL
- SODIUM PHOSPHATE, DIBASIC, ANHYDROUS142 mg/mL
Pharmacologic classes
Increased Large Intestinal Motility [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Osmotic Activity [MoA]; Osmotic Laxative [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 63323-886-56 | 63323088656 | 25 VIAL, SINGLE-DOSE in 1 TRAY (63323-886-56) / 50 mL in 1 VIAL, SINGLE-DOSE (63323-886-01) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/5bf47be3-f3fe-452b-8113-941796498345
Use it
Look up 63323-886 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/63323-886 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 63323-886. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.